ARCHIVES

ODAC Oks Carboplatin As 1st Line Ovarian Therapy; Other Drugs

This article is from The Cancer Letter archive.

Vol. 17 No. 28 | July 12, 1991

Download PDF Visit The Full Archive

Related Articles

Dietary Interventions Reduce Breast Cancer Risk In Trials

May 27, 2005

Cancer Atlast Offers New Research Leads

July 17, 1987

CAP Issues Active Surveillance Guidance For Prostate Cancer

September 5, 2014

In Brief: Pazdur to direct FDA Oncology Division; Ganz Awarded ACS Clinical Professorship

July 23, 1999

Micafungin Bests Fluconazole In Phase III Antifungal Trial

November 29, 2002

Bristol-Myers Adds UCLA, Fox Chase To Grants Program

April 12, 1985